Prazosin hydrochloride
USP/1554705 - United States Pharmacopeia (USP) Reference Standard
Synonym: 1-
CAS Number: 19237-84-4
Empirical Formula (Hill Notation): C19H21N5O4 · HCl
Molecular Weight: 419.86
MDL Number: MFCD00058177
Linear Formula: C19H21N5O4 · HCl
Product Type: Chemical
| API family | prazosin |
| application(s) | pharmaceutical (small molecule) |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/C19H21N5O4.ClH/c1-26-1 |
| InChI key | WFXFYZULCQKPIP-UHFFFAOYSA |
| manufacturer/tradename | USP |
| SMILES string | Cl.COc1cc2nc(nc(N)c2cc1OC |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | It was used as an α1-adrenergic receptors antagonist, in a study performed to understand the influence of dopamine on uterine motility of rats in vitro. |
| General description: | Prazosin hydrochloride is an alpha-adrenergic blocking agent, employed as an antihypertensive drug for the treatment of high blood pressure. It lowers the blood pressure by binding to the alpha receptors thereby relaxing the blood vessels. |
| Other Notes: | Sales restrictions may apply. |
| Symbol | ![]() GHS07,GHS08 |
| Signal word | Warning |
| Hazard statements | H302 - H315 - H319 - H335 - H361 |
| Precautionary statements | P201 - P301 + P312 + P330 - P302 + P352 - P305 + P351 + P338 - P308 + P313 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 41116107 |


